2026. THE ROLE OF DYSHORMONAL DISORDERS OF LEPTIN AND GHRELIN IN THE DEVELOPMENT OF DYSLIPIDEMIA AND METABOLIC SYNDROME. Modern American Journal of Medical and Health Sciences. 2, 3 (Mar. 2026), 7–16.